A Pilot Dose Escalation Trial of a Densified Chemotherapy Association of Docetaxel and Epirubicin Driven by Mathematical Modeling in Metastatic Breast Cancer Patients: The MODEL1 Study
Clinical trial NCT02392845 · COMPLETED
Trial details
- NCT number
- NCT02392845
- Sponsor
- Hospices Civils de Lyon
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2009-03-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.